490 related articles for article (PubMed ID: 16415928)
1. Coronavirus infection of the central nervous system: host-virus stand-off.
Bergmann CC; Lane TE; Stohlman SA
Nat Rev Microbiol; 2006 Feb; 4(2):121-32. PubMed ID: 16415928
[TBL] [Abstract][Full Text] [Related]
2. Perforin and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells.
Bergmann CC; Parra B; Hinton DR; Ramakrishna C; Dowdell KC; Stohlman SA
J Virol; 2004 Feb; 78(4):1739-50. PubMed ID: 14747539
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells.
Ramakrishna C; Stohlman SA; Atkinson RD; Shlomchik MJ; Bergmann CC
J Immunol; 2002 Feb; 168(3):1204-11. PubMed ID: 11801656
[TBL] [Abstract][Full Text] [Related]
4. IFN-gamma is required for viral clearance from central nervous system oligodendroglia.
Parra B; Hinton DR; Marten NW; Bergmann CC; Lin MT; Yang CS; Stohlman SA
J Immunol; 1999 Feb; 162(3):1641-7. PubMed ID: 9973424
[TBL] [Abstract][Full Text] [Related]
5. Role of the inflammasome-related cytokines Il-1 and Il-18 during infection with murine coronavirus.
Zalinger ZB; Elliott R; Weiss SR
J Neurovirol; 2017 Dec; 23(6):845-854. PubMed ID: 28895072
[TBL] [Abstract][Full Text] [Related]
6. Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system.
Bergmann CC; Altman JD; Hinton D; Stohlman SA
J Immunol; 1999 Sep; 163(6):3379-87. PubMed ID: 10477608
[TBL] [Abstract][Full Text] [Related]
7. CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection.
Trifilo MJ; Bergmann CC; Kuziel WA; Lane TE
J Virol; 2003 Apr; 77(7):4004-14. PubMed ID: 12634360
[TBL] [Abstract][Full Text] [Related]
8. Recruitment kinetics and composition of antibody-secreting cells within the central nervous system following viral encephalomyelitis.
Tschen SI; Bergmann CC; Ramakrishna C; Morales S; Atkinson R; Stohlman SA
J Immunol; 2002 Mar; 168(6):2922-9. PubMed ID: 11884463
[TBL] [Abstract][Full Text] [Related]
9. The art of survival during viral persistence.
Stohlman SA; Ramakrishna C; Tschen SI; Hinton DR; Bergmann CC
J Neurovirol; 2002 Dec; 8 Suppl 2():53-8. PubMed ID: 12491152
[TBL] [Abstract][Full Text] [Related]
10. Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease.
Walsh KB; Edwards RA; Romero KM; Kotlajich MV; Stohlman SA; Lane TE
J Immunol; 2007 Jul; 179(2):1155-65. PubMed ID: 17617609
[TBL] [Abstract][Full Text] [Related]
11. Contributions of CD8+ T cells and viral spread to demyelinating disease.
Marten NW; Stohlman SA; Atkinson RD; Hinton DR; Fleming JO; Bergmann CC
J Immunol; 2000 Apr; 164(8):4080-8. PubMed ID: 10754301
[TBL] [Abstract][Full Text] [Related]
12. Chemokine CXCL10 and Coronavirus-Induced Neurologic Disease.
Skinner D; Marro BS; Lane TE
Viral Immunol; 2019; 32(1):25-37. PubMed ID: 30109979
[TBL] [Abstract][Full Text] [Related]
13. Control of central nervous system viral persistence by neutralizing antibody.
Ramakrishna C; Bergmann CC; Atkinson R; Stohlman SA
J Virol; 2003 Apr; 77(8):4670-8. PubMed ID: 12663773
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of murine coronavirus in the central nervous system.
Bender SJ; Weiss SR
J Neuroimmune Pharmacol; 2010 Sep; 5(3):336-54. PubMed ID: 20369302
[TBL] [Abstract][Full Text] [Related]
15. The chemokine receptor CXCR2 and coronavirus-induced neurologic disease.
Weinger JG; Marro BS; Hosking MP; Lane TE
Virology; 2013 Jan; 435(1):110-7. PubMed ID: 23217621
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma secreted by virus-specific CD8+ T cells contribute to CNS viral clearance.
Parra B; Bergmann CC; Hinton DR; Atkinson R; Stohlman SA
Adv Exp Med Biol; 2001; 494():335-40. PubMed ID: 11774489
[No Abstract] [Full Text] [Related]
17. Single-Cell RNA Sequencing Reveals the Diversity of the Immunological Landscape following Central Nervous System Infection by a Murine Coronavirus.
Syage AR; Ekiz HA; Skinner DD; Stone C; O'Connell RM; Lane TE
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999036
[TBL] [Abstract][Full Text] [Related]
18. MHV infection of the CNS: mechanisms of immune-mediated control.
Marten NW; Stohlman SA; Bergmann CC
Viral Immunol; 2001; 14(1):1-18. PubMed ID: 11270593
[TBL] [Abstract][Full Text] [Related]
19. Anti-viral effector T cell responses and trafficking are not dependent upon DRAK2 signaling following viral infection of the central nervous system.
Ramos SJ; Hardison JL; Stiles LN; Lane TE; Walsh CM
Autoimmunity; 2007 Feb; 40(1):54-65. PubMed ID: 17364498
[TBL] [Abstract][Full Text] [Related]
20. Selective Packaging in Murine Coronavirus Promotes Virulence by Limiting Type I Interferon Responses.
Athmer J; Fehr AR; Grunewald ME; Qu W; Wheeler DL; Graepel KW; Channappanavar R; Sekine A; Aldabeeb DS; Gale M; Denison MR; Perlman S
mBio; 2018 May; 9(3):. PubMed ID: 29717007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
